Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Subtherapeutic concentrations of first-line anti-TB drugs in South African children treated according to current guidelines: the PHATISA study.

Autor: Hiruy H; Center for Tuberculosis Research, Department of Medicine, JHU, Baltimore, MD 21287, USA., Rogers Z; Kwazulu-Natal Research Institute for TB and HIV, Durban 4001, South Africa., Mbowane C; Department of Pediatrics, Nelson Mandela School of Medicine, UKZN, Durban 4001, South Africa., Adamson J; Kwazulu-Natal Research Institute for TB and HIV, Durban 4001, South Africa., Ngotho L; Kwazulu-Natal Research Institute for TB and HIV, Durban 4001, South Africa., Karim F; Kwazulu-Natal Research Institute for TB and HIV, Durban 4001, South Africa., Gumbo T; Office of Global Health, University of Texas Southwestern Medical School, Dallas, TX 75390, USA., Bishai W; Center for Tuberculosis Research, Department of Medicine, JHU, Baltimore, MD 21287, USA Kwazulu-Natal Research Institute for TB and HIV, Durban 4001, South Africa Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA wbishai@jhmi.edu., Jeena P; Department of Pediatrics, Nelson Mandela School of Medicine, UKZN, Durban 4001, South Africa.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2015 Apr; Vol. 70 (4), pp. 1115-23. Date of Electronic Publication: 2014 Dec 11.